Why rely on one method when three are better? Ezra CEO Emi Gal explains how combining imaging, liquid biopsy, and biomarkers creates a superior cancer screening protocol. He also shares how AI enables longitudinal tracking of lesions, reducing false positives and patient anxiety. Learn what makes Ezra’s approach uniquely effective in the fight against cancer.
--------
5:51
--------
5:51
How AI Makes Full-Body MRI Faster and Cheaper
Discover how Ezra uses FDA-cleared AI to transform MRI imaging. CEO Emi Gal explains how Ezra Flash speeds up scan times while improving quality, and how Ezra Assist aids radiologists with accurate annotations. Their AI-powered process makes full-body cancer screening possible in just 22 minutes—for under $500. Learn how this innovation is redefining medical imaging from acquisition to interpretation.
--------
12:01
--------
12:01
Should Patients Be Paid for Sharing Health Data?
Can patients and clinicians be fairly rewarded for sharing healthcare data? Rajeev Ronanki, CEO of Lyric, discusses a future where AI-enabled tools empower community oncology practices with personalized digital agents. He outlines how reimbursement models can support physicians scaling their care using AI, and why rewarding patient data sharing is both ethical and economically sound.
--------
5:39
--------
5:39
AI Makes Full Body MRI Screening Affordable - with Emi Gal
Ezra CEO Emi Gal breaks down how AI is revolutionizing full-body MRI cancer screening. Learn how FDA-cleared tools accelerate scan time, assist radiologists, and empower patients with easy-to-understand reports—all for just $499. Discover why early detection matters, especially for younger adults, and how Ezra is scaling access to lifesaving diagnostics.
--------
37:30
--------
37:30
Inside the FDA’s Bold Elsa AI Move: Rajeev Ronanki Explains
Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes.
This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and VP of Clinical AI at Tempus AI, as they explore cutting-edge innovations with industry pioneers.
Originally launched as the TARGET: Cancer Podcast in 2021, the series evolved after 75 episodes into a comprehensive platform for AI and healthcare conversations.
Netherlands